-
3
-
-
37049242417
-
Waterfall sequence for intrinsic blood clotting
-
Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964;145:1310-1312
-
(1964)
Science
, vol.145
, pp. 1310-1312
-
-
Davie, E.W.1
Ratnoff, O.D.2
-
4
-
-
37049044629
-
An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier
-
MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature (London) 1964;202:498-499
-
(1964)
Nature (London)
, vol.202
, pp. 498-499
-
-
MacFarlane, R.G.1
-
6
-
-
0001993927
-
Tissue factor pathway inhibitor - A regulator of tissue factor induced coagulation
-
Green D, ed. Florida: CRC Press
-
Bajaj MS, Ameri A, Bajaj SP. Tissue factor pathway inhibitor - A regulator of tissue factor induced coagulation. In: Green D, ed. Anticoagulants: Physiologic, Pathologic and Pharmacologic. Florida: CRC Press; 1994:41-65
-
(1994)
Anticoagulants: Physiologic, Pathologic and Pharmacologic
, pp. 41-65
-
-
Bajaj, M.S.1
Ameri, A.2
Bajaj, S.P.3
-
7
-
-
0017639138
-
Activation of factor IX by the reaction product of tissue factor and factor VII. Additional pathway for initiating blood coagulation
-
Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII. Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977;74:5260-5264
-
(1977)
Proc Natl Acad Sci USA
, vol.74
, pp. 5260-5264
-
-
ØSterud, B.1
Rapaport, S.I.2
-
8
-
-
0020500234
-
Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor
-
Bajaj SP, Rapaport SI, Russell WA. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Biochemistry 1983;22:4047-4053
-
(1983)
Biochemistry
, vol.22
, pp. 4047-4053
-
-
Bajaj, S.P.1
Rapaport, S.I.2
Russell, W.A.3
-
9
-
-
0022852730
-
Intrinsic versus extrinsic coagulation: Kinetic considerations
-
Warn-Cramer BJ, Bajaj SP. Intrinsic versus extrinsic coagulation: Kinetic considerations. Biochem J 1986;239:757-762
-
(1986)
Biochem J
, vol.239
, pp. 757-762
-
-
Warn-Cramer, B.J.1
Bajaj, S.P.2
-
10
-
-
0024997547
-
Factor IX is activated by the tissue factor mechanism
-
Bauer KA, Kass BL, ten Cate H, Hawiger JL, Rosenberg RD. Factor IX is activated by the tissue factor mechanism. Blood 1990;76:731-736
-
(1990)
Blood
, vol.76
, pp. 731-736
-
-
Bauer, K.A.1
Kass, B.L.2
Ten Cate, H.3
Hawiger, J.L.4
Rosenberg, R.D.5
-
11
-
-
0023851758
-
Tissue factor and hemostasis
-
Nemerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8
-
(1988)
Blood
, vol.71
, pp. 1-8
-
-
Nemerson, Y.1
-
12
-
-
0026337077
-
The coagulation cascade: Initiation, maintenance, and regulation
-
David EW, Fujikawa K, Kisiel W. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 1991;30: 10363-10370
-
(1991)
Biochemistry
, vol.30
, pp. 10363-10370
-
-
David, E.W.1
Fujikawa, K.2
Kisiel, W.3
-
13
-
-
0028869947
-
Definition of the bleeding tendency in factor XI-deficient kindreds - A clinical and laboratory study
-
Bolton-Maggs PHB, Patterson DA, Wensley RT, Tuddenham EGD. Definition of the bleeding tendency in factor XI-deficient kindreds - A clinical and laboratory study. Thromb Haemost 1995;73:194-202
-
(1995)
Thromb Haemost
, vol.73
, pp. 194-202
-
-
Bolton-Maggs, P.H.B.1
Patterson, D.A.2
Wensley, R.T.3
Tuddenham, E.G.D.4
-
14
-
-
0021987658
-
Comparison of bleeding tendency, factor XI coagulant activity and factor XI antigen in twenty-five factor XI deficient kindreds
-
Ragni MV, Sinha D, Seaman F, et al. Comparison of bleeding tendency, factor XI coagulant activity and factor XI antigen in twenty-five factor XI deficient kindreds. Blood 1985; 65:719-724
-
(1985)
Blood
, vol.65
, pp. 719-724
-
-
Ragni, M.V.1
Sinha, D.2
Seaman, F.3
-
16
-
-
0025788582
-
Activation of human blood coagulation factor XI independent of factor XII. Factor XIa is activated by thrombin and factor XIa in the presence of negatively charged surface
-
Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XIa is activated by thrombin and factor XIa in the presence of negatively charged surface. J Biol Chem 1991;266:7353-7358
-
(1991)
J Biol Chem
, vol.266
, pp. 7353-7358
-
-
Naito, K.1
Fujikawa, K.2
-
17
-
-
0025874052
-
Factor XI activation in a revised model of blood coagulation
-
Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science 1991;253:909-912
-
(1991)
Science
, vol.253
, pp. 909-912
-
-
Gailani, D.1
Broze, G.J.2
-
18
-
-
0026482144
-
Fibrinogen blocks the autoactivation of factor XI on dextran sulfate
-
Scott CF, Colman RW. Fibrinogen blocks the autoactivation of factor XI on dextran sulfate. Proc Natl Acad Sci USA 1992;89:11189-11193
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 11189-11193
-
-
Scott, C.F.1
Colman, R.W.2
-
19
-
-
0028843737
-
Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis
-
von dem Borne PAK, Meijers JCM, Bouma BN. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995;86:3035-3042
-
(1995)
Blood
, vol.86
, pp. 3035-3042
-
-
Von Dem Borne, P.A.K.1
Meijers, J.C.M.2
Bouma, B.N.3
-
20
-
-
2642651894
-
Blood coagulation in hemophilia A and hemophilia C
-
Cawthern KM, van 't Veer C, Lock JB, et al. Blood coagulation in hemophilia A and hemophilia C. Blood 1998;91:4581-4592
-
(1998)
Blood
, vol.91
, pp. 4581-4592
-
-
Cawthern, K.M.1
Van 't Veer, C.2
Lock, J.B.3
-
22
-
-
85088673705
-
When and where is factor XI activated by thrombin?
-
Letter
-
Colman RW, Scott CF. When and where is factor XI activated by thrombin? Blood 1996;87:2089-2091. Letter
-
(1996)
Blood
, vol.87
, pp. 2089-2091
-
-
Colman, R.W.1
Scott, C.F.2
-
23
-
-
0030872898
-
The structural basis of function of the TF-VIIa complex in the cellular initiation of coagulation
-
Edgington TS, Dickinson CD, Ruf W. The structural basis of function of the TF-VIIa complex in the cellular initiation of coagulation. Thromb Haemost 1997;78:401-405
-
(1997)
Thromb Haemost
, vol.78
, pp. 401-405
-
-
Edgington, T.S.1
Dickinson, C.D.2
Ruf, W.3
-
24
-
-
0030068977
-
Kinetics of human factor VII activation
-
Butenas S, Mann KG. Kinetics of human factor VII activation. Biochemistry 1996;35:1904-1910
-
(1996)
Biochemistry
, vol.35
, pp. 1904-1910
-
-
Butenas, S.1
Mann, K.G.2
-
25
-
-
0026689166
-
Measurement of basal levels of factor VIIa in hemophilia A and B patients
-
Wildgoose P, Nemerson Y, Hansen LL, et al. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992;80:25-28
-
(1992)
Blood
, vol.80
, pp. 25-28
-
-
Wildgoose, P.1
Nemerson, Y.2
Hansen, L.L.3
-
26
-
-
0028818742
-
Determinants of plasma factor VIIa levels in humans
-
Eichinger S, Mannucci PM, Tradati F, et al. Determinants of plasma factor VIIa levels in humans. Blood 1995;86:3021-3025
-
(1995)
Blood
, vol.86
, pp. 3021-3025
-
-
Eichinger, S.1
Mannucci, P.M.2
Tradati, F.3
-
27
-
-
0029917898
-
Studies of activation of factor VII bound to tissue factor
-
Rao LVM, Williams T, Rapaport SI. Studies of activation of factor VII bound to tissue factor. Blood 1996;87:3738-3748
-
(1996)
Blood
, vol.87
, pp. 3738-3748
-
-
Rao, L.V.M.1
Williams, T.2
Rapaport, S.I.3
-
28
-
-
0026355315
-
Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII
-
Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991;30:10819-10824
-
(1991)
Biochemistry
, vol.30
, pp. 10819-10824
-
-
Nakagaki, T.1
Foster, D.C.2
Berkner, K.L.3
Kisiel, W.4
-
29
-
-
0027494426
-
Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism
-
Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem 1993;268:21489-21492
-
(1993)
J Biol Chem
, vol.268
, pp. 21489-21492
-
-
Neuenschwander, P.F.1
Fiore, M.M.2
Morrissey, J.H.3
-
30
-
-
0025311157
-
Surface dependent reactions of the vitamin K-dependent enzyme complexes
-
Mann KG, Neshcim ME, Church WR, Haley P, Krishnaswamy S. Surface dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990;76:1-16
-
(1990)
Blood
, vol.76
, pp. 1-16
-
-
Mann, K.G.1
Neshcim, M.E.2
Church, W.R.3
Haley, P.4
Krishnaswamy, S.5
-
31
-
-
0030745169
-
Factor VIIa-tissue factor: Functional importance of protein-membrane interactions
-
Morrissey JH, Neuenschwander PF, Huang Q. et al. Factor VIIa-tissue factor: Functional importance of protein-membrane interactions. Thromb Haemost 1997;78:112-116
-
(1997)
Thromb Haemost
, vol.78
, pp. 112-116
-
-
Morrissey, J.H.1
Neuenschwander, P.F.2
Huang, Q.3
-
32
-
-
0003260971
-
Hemophilia and related conditions -inherited deficiencies of prothrombin (factor II), factor V, and factors VII to XII
-
Benther E, Lichtman MA, Coller BS, Kipps TJ, eds. New York: MacGraw-Hill
-
Roberts HR, Hoffman M. Hemophilia and related conditions -inherited deficiencies of prothrombin (factor II), factor V, and factors VII to XII. In: Benther E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams' Hematology, 5th ed. New York: MacGraw-Hill; 1995:135-158
-
(1995)
Williams' Hematology, 5th Ed.
, pp. 135-158
-
-
Roberts, H.R.1
Hoffman, M.2
-
33
-
-
0029153045
-
The tissue factor pathway: How it has become a "prima ballerina."
-
Rapaport SI, Rao LVM. The tissue factor pathway: How it has become a "prima ballerina." Thromb Haemost 1995;74:7-17
-
(1995)
Thromb Haemost
, vol.74
, pp. 7-17
-
-
Rapaport, S.I.1
Rao, L.V.M.2
-
34
-
-
0029144243
-
Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation
-
Hoffman M, Monroe DM, Oliver JA, Roberts HR. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995;86:1794-1801
-
(1995)
Blood
, vol.86
, pp. 1794-1801
-
-
Hoffman, M.1
Monroe, D.M.2
Oliver, J.A.3
Roberts, H.R.4
-
35
-
-
0028932993
-
Tissue factor pathway inhibitor and the revised theory of blood coagulation
-
Broze GJ Jr. Tissue factor pathway inhibitor and the revised theory of blood coagulation. Annu Rev Med 1995;46:103-112
-
(1995)
Annu Rev Med
, vol.46
, pp. 103-112
-
-
Broze G.J., Jr.1
-
36
-
-
0025772165
-
Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation
-
Lawson JH, Mann KG. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem 1991;266:11317-11327
-
(1991)
J Biol Chem
, vol.266
, pp. 11317-11327
-
-
Lawson, J.H.1
Mann, K.G.2
-
37
-
-
0027475222
-
Complex dependent inhibition of factor VIIa by antithrombin III and heparin
-
Lawson JH, Butenas S, Ribarik N, Mann KG. Complex dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 1993;268:767-770
-
(1993)
J Biol Chem
, vol.268
, pp. 767-770
-
-
Lawson, J.H.1
Butenas, S.2
Ribarik, N.3
Mann, K.G.4
-
38
-
-
0027263354
-
Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa
-
Rao LVM, Rapaport SI, Hoang AD. Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 1993;81:2600-2607
-
(1993)
Blood
, vol.81
, pp. 2600-2607
-
-
Rao, L.V.M.1
Rapaport, S.I.2
Hoang, A.D.3
-
39
-
-
0024991650
-
Regulation of coagulation by a multivalent Kunitz-type inhibitor
-
Broze GJ Jr, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990;29: 7539-7544
-
(1990)
Biochemistry
, vol.29
, pp. 7539-7544
-
-
Broze G.J., Jr.1
Girard, T.J.2
Novotny, W.F.3
-
40
-
-
0025222311
-
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principal site of its synthesis
-
Bajaj MS, Kuppuswamy MN, Galto H, Spitzer SG, Bajaj SP. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: Evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci USA 1990;87:8869-8873
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 8869-8873
-
-
Bajaj, M.S.1
Kuppuswamy, M.N.2
Galto, H.3
Spitzer, S.G.4
Bajaj, S.P.5
-
41
-
-
0029053481
-
Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions
-
Østerud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. Thromb Haemost 1995;73:873-875
-
(1995)
Thromb Haemost
, vol.73
, pp. 873-875
-
-
ØSterud, B.1
Bajaj, M.S.2
Bajaj, S.P.3
-
42
-
-
0025371509
-
Protease nexin-II (amyloid beta-protein precursor): A platelet alpha-granule protein
-
Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin-II (amyloid beta-protein precursor): A platelet alpha-granule protein. Science 1990;248:745-748
-
(1990)
Science
, vol.248
, pp. 745-748
-
-
Van Nostrand, W.E.1
Schmaier, A.H.2
Farrow, J.S.3
Cunningham, D.D.4
-
43
-
-
0025365401
-
Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein
-
Smith RP, Higuchi DA, Broze GJ Jr. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 1990;248:1126-1128
-
(1990)
Science
, vol.248
, pp. 1126-1128
-
-
Smith, R.P.1
Higuchi, D.A.2
Broze G.J., Jr.3
-
44
-
-
0002613087
-
Overview of hemostasis
-
Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia: Lippincott
-
Colman RW, Marder VJ, Salzman EW, Hirsh J. Overview of hemostasis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia: Lippincott; 1994:3-18
-
(1994)
Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd Ed.
, pp. 3-18
-
-
Colman, R.W.1
Marder, V.J.2
Salzman, E.W.3
Hirsh, J.4
-
45
-
-
0001976355
-
The protein C antiocoagulant system
-
Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. Philadelphia: Saunders
-
Dahlbäck B, Stenflo J. The protein C antiocoagulant system. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Disease. Philadelphia: Saunders; 1994:599-627
-
(1994)
The Molecular Basis of Blood Disease
, pp. 599-627
-
-
Dahlbäck, B.1
Stenflo, J.2
-
46
-
-
0029381847
-
Cellular regulation of protein C pathway
-
Esmon CT, Fukudome K. Cellular regulation of protein C pathway. Semin Cell Biol 1995;6:259-268
-
(1995)
Semin Cell Biol
, vol.6
, pp. 259-268
-
-
Esmon, C.T.1
Fukudome, K.2
-
47
-
-
13344276582
-
Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C
-
Koppelman SJ, van Hoeij M, Vink T, et al. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C. Blood 1996;87:2292-2300
-
(1996)
Blood
, vol.87
, pp. 2292-2300
-
-
Koppelman, S.J.1
Van Hoeij, M.2
Vink, T.3
-
48
-
-
0028211344
-
Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: A mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis
-
Loza J-P, Gurewich V, Johnstone M, Pannell R. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: A mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis. Thromb Haemost 1994;71:347-352
-
(1994)
Thromb Haemost
, vol.71
, pp. 347-352
-
-
Loza, J.-P.1
Gurewich, V.2
Johnstone, M.3
Pannell, R.4
-
49
-
-
51849180721
-
Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: Problems and possible solutions
-
Barna L, Triplett DA. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: Problems and possible solutions. Res Clin Lab 1989;19:345-354
-
(1989)
Res Clin Lab
, vol.19
, pp. 345-354
-
-
Barna, L.1
Triplett, D.A.2
-
50
-
-
0021137174
-
Comparison of the sensitivity of commercial APTT reagents in the detection of mild coagulopathies
-
Marlar RA, Bauer PJ, Endes-Brooks JL, et al. Comparison of the sensitivity of commercial APTT reagents in the detection of mild coagulopathies. Am J Clin Pathol 1984;82:436-439
-
(1984)
Am J Clin Pathol
, vol.82
, pp. 436-439
-
-
Marlar, R.A.1
Bauer, P.J.2
Endes-Brooks, J.L.3
-
51
-
-
0022654149
-
Sampling of three activated partial thromboplastin time reagents to coagulation factor deficiencies
-
Turi DC, Purschke EI. Sampling of three activated partial thromboplastin time reagents to coagulation factor deficiencies. Am J Clin Pathol 1986;85:43-49
-
(1986)
Am J Clin Pathol
, vol.85
, pp. 43-49
-
-
Turi, D.C.1
Purschke, E.I.2
-
52
-
-
0345030637
-
Acquired coagulation disorders
-
Philadelphia: Lippincott
-
Rapaport SI. Acquired coagulation disorders. In: Introduction to Hematology, 2nd ed. Philadelphia: Lippincott; 1987;541-557
-
(1987)
Introduction to Hematology, 2nd Ed.
, pp. 541-557
-
-
Rapaport, S.I.1
-
53
-
-
51849181037
-
Screening for the lupus anticoagulant
-
Triplett DA. Screening for the lupus anticoagulant. Res Clin Lab 1989;19:379-389
-
(1989)
Res Clin Lab
, vol.19
, pp. 379-389
-
-
Triplett, D.A.1
-
54
-
-
0030014877
-
The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays
-
Kitchen J, Preston FE. The therapeutic range for heparin therapy: Relationship between six activated partial thromboplastin time reagents and two heparin assays. Thromb Haemost 1996;75: 734-739
-
(1996)
Thromb Haemost
, vol.75
, pp. 734-739
-
-
Kitchen, J.1
Preston, F.E.2
-
55
-
-
0344599730
-
Laboratory monitoring of heparin therapy
-
Joist JH, Hyers T. Laboratory monitoring of heparin therapy. Thromb Forum 1995;1:1-4
-
(1995)
Thromb Forum
, vol.1
, pp. 1-4
-
-
Joist, J.H.1
Hyers, T.2
-
56
-
-
0028292164
-
Low molecular weight heparin: Laboratory properties and clinical evaluation. A review
-
Hirsh J, Levine MN. Low molecular weight heparin: Laboratory properties and clinical evaluation. A review. Eur J Surg 1194;571(suppl):9-22
-
(1194)
Eur J Surg
, vol.571
, Issue.SUPPL.
, pp. 9-22
-
-
Hirsh, J.1
Levine, M.N.2
-
57
-
-
0000919840
-
Approach to the bleeding patient
-
Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Philadelphia: Lippincott
-
White GC, Marder VJ, Colman RW, Hirsh J, Salzman EW. Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia: Lippincott; 1994:1134-1147
-
(1994)
Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd Ed.
, pp. 1134-1147
-
-
White, G.C.1
Marder, V.J.2
Colman, R.W.3
Hirsh, J.4
Salzman, E.W.5
-
58
-
-
0020604029
-
A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome
-
Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983;61:684-692
-
(1983)
Blood
, vol.61
, pp. 684-692
-
-
Bajaj, S.P.1
Rapaport, S.I.2
Fierer, D.S.3
Herbst, K.D.4
Schwartz, D.B.5
-
59
-
-
0014436318
-
Kinetic aspects of the interaction of blood clotting enzymes. III. Demonstrations of an inhibitor of prothrombin conversion in vitamin K deficiency
-
Hemker HC, Veltkamp JJ, Loeliger EA. Kinetic aspects of the interaction of blood clotting enzymes. III. Demonstrations of an inhibitor of prothrombin conversion in vitamin K deficiency. Thrombosis et Diathesis Haemorrhagica 1968;19:346-351
-
(1968)
Thrombosis et Diathesis Haemorrhagica
, vol.19
, pp. 346-351
-
-
Hemker, H.C.1
Veltkamp, J.J.2
Loeliger, E.A.3
-
60
-
-
0006574613
-
Monitoring oral anticoagulant therapy
-
Jensen R. Monitoring oral anticoagulant therapy. Clin Hemost Rev 1996;10:1-5
-
(1996)
Clin Hemost Rev
, vol.10
, pp. 1-5
-
-
Jensen, R.1
-
61
-
-
0026078837
-
Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant
-
Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SI, Rapaport SI. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: Evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci USA 1991;88: 708-712
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 708-712
-
-
Sandset, P.M.1
Warn-Cramer, B.J.2
Rao, L.V.M.3
Maki, S.I.4
Rapaport, S.I.5
-
62
-
-
0030745177
-
Tissue factor pathway inhibitor: Potential therapeutic applications
-
Bajaj MS, Bajaj SP. Tissue factor pathway inhibitor: Potential therapeutic applications. Thromb Haemost 1997; 78:471-477
-
(1997)
Thromb Haemost
, vol.78
, pp. 471-477
-
-
Bajaj, M.S.1
Bajaj, S.P.2
-
63
-
-
0030775316
-
Mice lacking factor VII develop normally but suffer fatal perinatal bleeding
-
Rosen ED, Chan JCY, Idusogie E, et al. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 1997;390:290-293
-
(1997)
Nature
, vol.390
, pp. 290-293
-
-
Rosen, E.D.1
Chan, J.C.Y.2
Idusogie, E.3
-
64
-
-
0029908545
-
Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation
-
Bugge TH, Xiao Q, Kombrinck KW, et al. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996;93:6258-6262
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 6258-6262
-
-
Bugge, T.H.1
Xiao, Q.2
Kombrinck, K.W.3
-
65
-
-
0029794555
-
Targeted disruption of the murine tissue factor gene results in embryonic lethality
-
Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996;88:1583-1587
-
(1996)
Blood
, vol.88
, pp. 1583-1587
-
-
Toomey, J.R.1
Kratzer, K.E.2
Lasky, N.M.3
Stanton, J.J.4
Broze G.J., Jr.5
-
66
-
-
9544227474
-
Role of tissue factor in embryonic blood vessel development
-
Carmeliet P, Mackman N, Moons L, et al. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383:73-75
-
(1996)
Nature
, vol.383
, pp. 73-75
-
-
Carmeliet, P.1
Mackman, N.2
Moons, L.3
-
67
-
-
0030742910
-
Consequences of tissue factor pathway inhibitor gene-disruption in mice
-
Huang Z-F, Broze G Jr. Consequences of tissue factor pathway inhibitor gene-disruption in mice. Thromb Haemost 1997;78 699-704
-
(1997)
Thromb Haemost
, vol.78
, pp. 699-704
-
-
Huang, Z.-F.1
Broze G., Jr.2
-
69
-
-
0030830360
-
Contact system: A vascular modulator with anticoagulant, profibrinolytic, antiadhesive and proinflammatory attributes
-
Colman RW, Schmaier AH. Contact system: A vascular modulator with anticoagulant, profibrinolytic, antiadhesive and proinflammatory attributes. Blood 1997;90:3819-3843
-
(1997)
Blood
, vol.90
, pp. 3819-3843
-
-
Colman, R.W.1
Schmaier, A.H.2
-
70
-
-
0030042202
-
Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding
-
Ambrosini G, Altieri DC. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding. J Biol Chem 1996;271:1243-1248
-
(1996)
J Biol Chem
, vol.271
, pp. 1243-1248
-
-
Ambrosini, G.1
Altieri, D.C.2
-
71
-
-
0027943163
-
Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor
-
Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994;269:26486-26491
-
(1994)
J Biol Chem
, vol.269
, pp. 26486-26491
-
-
Fukudome, K.1
Esmon, C.T.2
-
72
-
-
0032874149
-
Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin, and von Willebrand factor in normal human tissues
-
in press
-
Bajag MS, Kuppuswamy MN, Manepalli AN, et al. Transcriptional expression of tissue factor pathway inhibitor, Thrombomodulin, and von Willebrand factor in normal human tissues. Thrombos Haemostas 1999; (in press)
-
(1999)
Thrombos Haemostas
-
-
Bajag, M.S.1
Kuppuswamy, M.N.2
Manepalli, A.N.3
-
73
-
-
0032752927
-
Synthesis and expression of tissue factor way inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells, and cardiac myocytes
-
in press
-
Bajaj MS, Steer S, Kuppuswamy MN, et al. Synthesis and expression of tissue factor way inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells, and cardiac myocytes. Thrombos Haemstas 1999; (in press)
-
(1999)
Thrombos Haemstas
-
-
Bajaj, M.S.1
Steer, S.2
Kuppuswamy, M.N.3
|